PROMISE: Our kitties will never sit on top of content. Please turn off your ad blocker for our site.
puuuuuuurrrrrrrrrrrr
The QA Pharm
Published: Monday, July 27, 2015 - 15:39 Verifying the effectiveness of corrective and preventive actions (CAPAs) closes the loop between identifying a problem and completing the actions to solve it. It’s reasonable to assume that if a problem is worth solving, it’s also worth verifying that the solution worked. However, given the wide range of problems that could occur, determining the best verification approach and time frame to implement it can often seem elusive. Before we discuss CAPA effectiveness, we need to look at a few of the reasons why performing this check is often a challenge. Here are six: Assuming we have a real CAPA, where an investigation was conducted on a well-defined problem to determine the root cause and product impact, we can turn to the regulatory requirements and business obligation to evaluate how well we spent our resources to eliminate the problem permanently. This brings us to options for verifying CAPA effectiveness. Here are six: Now that we have a real CAPA and a selected a method to verify its effectiveness, we must determine an appropriate time frame to perform the verification. Time frames are subjective, but there must be a basis for the decision. Here are points to consider when determining an appropriate time frame for CAPA effectiveness verification. Allow relatively less time after implementing the solution when there is: In these cases, fewer observations are needed for a high degree of confidence. Allow relatively more time after implementing the solution when there is: In these cases, more observations are needed for a high degree of confidence. Following are several fictitious examples of CAPAs that require an effectiveness verification. Which CAPA verification effectiveness method and time frame would you recommend? Example one Root cause: There is a general lack of understanding of acceptable CAPA effectiveness review methods that would satisfy the procedural requirement. CAPA: Develop and deliver targeted training on CAPA effectiveness verification methods to CAPA system users who have the responsibility to make this determination. Example two Root cause: Labels made on the current label printer are frequently unreadable. CAPA: Replace the current label printer with one that produces legible labels. Example three Root cause: The instructions in SOP XYZ123 are more interpretive than intended, which can mislead inexperienced operators. CAPA: Revise SOP XYZ123 to be more specific about the required number and specific placement of micro-plates in Room A. Example four Root cause: The phosphate buffered saline delivery piping system upstream of the microfilter exhibited high bioburden levels. CAPA: Revise the cleaning procedure to incorporate water for injection fish to remove residual harvest material from the process piping, and provide training on the flushing process. Example five Root cause: There was a difference in sample preparation techniques between the two sites. CAPA: Revise the sample preparation of the test method to establish consistency between sites, and provide training on revised test method. First published March 17, 2015, on The QA Pharm blog. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks, The QA Pharm is a service of John Snyder & Co. Inc., provider of consulting services to FDA-regulated companies to build quality management systems and develop corrective actions that address regulatory compliance observations and communication strategies to protect against enforcement action. John E. Snyder worked at the lab bench, on the management board, and as an observer of the pharmaceutical industry for more than 30 years. His posts on The QA Pharm blog are straight talk about the challenges faced by company management and internal quality professionals. Synder is the author of Murder for Diversion (Jacob Blake Pharma Mystery Series Book 1). Six Methods for Verifying CAPA Effectiveness
How to choose the right method and time frame
• The problem isn’t well defined. Sometimes breaking the mental logjam is as simple as asking, “What problem were we trying to solve?” That sounds like an easy question, but when the answer isn’t well defined or stated simply, measuring success isn’t easy to do.
• The root cause isn’t determined. This is a natural consequence of the first reason. It’s next to impossible to determine the root cause for a fuzzy problem, or one that seems too complicated to explain. Those who try also get a fuzzy root cause.
• It’s not really a CAPA. All too often, the CAPA system has become a quality work-order system (aka dumping ground) because the commonly used data management systems, such as Trackwise, provide project management structure and visibility. But without a stated problem or determining a root cause, it’s not a CAPA; it’s just a project.
• CAPA effectiveness verification is used for everything. CAPA effectiveness verification can be too much of a good thing when it’s expected for every possible CAPA. This usually occurs from the cascading problem of a CAPA being required for every deviation, and a deviation being required for every conceivable blip. Soon you become a drowning victim of your own making.
• We overthink it. Rather than allowing reason to prevail, there are those who tend to complicate just about everything. Determining and applying an appropriate verification method is no exception. Yes, we operate in a scientific environment, but not every method of verifying effectiveness must be labor-intensive. Major processes need not be applied to minor problems.
• It’s not considered important. There are those who believe that living with an ongoing problem is the path of least resistance, especially when compared to conducting the same boilerplate investigation (i.e., same problem, different day) in order to get on with the real work of production. Having a low tolerance for recurring problems is truly the root cause for many who are treading water in a deviation-swirling tide pool.
• Auditing is used when the solution involves changes to a system and a verification is done to see whether the changes are in place procedurally and in use behaviorally. An example is an audit of a new-line clearance checklist to verify effective implementation of the checklist.
• Spot check is used for random observations of performance or reviews of records. Spot checks provide immediate but limited feedback. An example is a spot-check of batch records to ensure that the pH step was performed correctly after training on the new procedure.
• Sampling is used for observations of variables or attributes, per defined sampling plan. An example of sampling a statistical sample randomly drawn from lot XYZ123 to confirm that a defect has been removed after implementing a process improvement.
• Monitoring is used for real-time observations over a defined period. An example of monitoring is real-time observation to verify that changes to operator-owning practices were implemented.
• Trend analysis is the retrospective review of data to verify that expected results were achieved. An example of trend analysis is the review of environmental monitoring (EM) data for the period covering the last 30 batches to show the downward trend in EM excursions due to process improvements.
• Periodic product review is a retrospective review of trends of multiple parameters done at least annually to confirm the state of control. An example of periodic product review is the review of data after major changes were made to the facility and equipment as part of a process technology upgrade following a recall.
• Higher opportunity for occurrence and observation
• Higher probability of detection
• An engineered solution
• Lower opportunity for occurrence and observation
• Lower probability of detection
• A behavioral or training solution
Problem: There are widespread errors in selecting an appropriate effectiveness verification and time frame in the Trackwise fields when compared to the requirement in the new procedure.
Problem: Transcription errors are being made when copying information from sample ID labels to laboratory notebooks.
Problem: The incorrect number of microbiological plates, as required by SOP XYZ123, were delivered to the lab on two separate occasions by a newly trained operator after routine sanitization of Room A.
Problem: Increased bioburden levels were noted in the microfiltration process train A.
Problem: A statistically significant trend was observed in assay X results for six lots of the 25 mg vial manufactured at site A, but not the 10 mg vial manufactured at site B for the same period.
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
The QA Pharm
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.